A bruton’s tyrosine kinase inhibitor reduces stemness and invasiveness of patient-derived glioblastoma tumorspheres
Ontology highlight
ABSTRACT: A bruton’s tyrosine kinase inhibitor reduces stemness and invasiveness of patient-derived glioblastoma tumorspheres
PROVIDER: PRJNA1215729 | ENA |
REPOSITORIES: ENA
ACCESS DATA